The U.S. Food and Drug Administration (FDA) met in order to improve the warnings placed on low-testosterone replacement drugs. The meeting was also to discuss the appropriate ages for men to take this type of drug and to upgrade the drug’s warning label.
Multitudes of low-testosterone treatment lawsuits have been filed against the drug producers claiming that there were not proper warnings about the drug’s side effects.
In the meeting between the FDA and the Bone, Reproductive and Urologic Drugs Advisory Committee, the groups discussed changing the drug warning. Currently, the drug label only states that the drug may cause blood clots in people that already have an excessively high amount of red blood cells. However, the panel is changing this label to show that blood clots may occur from low-testosterone treatments even in patients that have regular blood cell counts.
The FDA has further announced that it will be conducting studies to determine if low-testosterone drugs may cause strokes and heart attacks, and which age group would be the most susceptible to this.
If you’ve taken testosterone replacement drugs and have experienced any negative side-effects or feel the warning labels weren’t sufficient enough, please contact Long & Long. Our experienced Alabama defective product attorneys have the experience you need to get you the settlement you deserve. We serve clients in Mobile, Alabama and the surrounding areas. Call us today at (251) 432-2277.